Trials / Completed
CompletedNCT06899620
BC179 Relieves Discomfort After Drinking
Weizmannia Coagulans BC179 Alleviates Post-Alcohol Discomfort May Via Taurine-Related Metabolism and Antioxidant Regulation: A Randomized, Double-Blind，Placebo-Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Wecare Probiotics Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To assess the effectiveness and safety of probiotic strain BC179 in reducing alcohol absorption in the gut, thereby lowering health risks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic group | The experimental phase of this study lasted for 60 days. |
| DIETARY_SUPPLEMENT | Placebo group | The experimental phase of this study lasted for 60 days. |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2024-11-30
- Completion
- 2025-07-20
- First posted
- 2025-03-28
- Last updated
- 2025-08-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06899620. Inclusion in this directory is not an endorsement.